A Study in Healthy Infants of the Safety Tolerability and Immunogenicity of Haemophilus Influenzae Type b/Hepatitis B Vaccine Manufactured With a Modified Process.

Trial Profile

A Study in Healthy Infants of the Safety Tolerability and Immunogenicity of Haemophilus Influenzae Type b/Hepatitis B Vaccine Manufactured With a Modified Process.

Completed
Phase of Trial: Phase III

Latest Information Update: 09 Jun 2014

At a glance

  • Drugs Hib-hepatitis B vaccine (Primary) ; Aluminium hydroxyphosphate sulfate
  • Indications Haemophilus infections; Hepatitis B
  • Focus Pharmacodynamics; Registrational
  • Sponsors Merck & Co
  • Most Recent Events

    • 26 Aug 2011 Results published in Vaccine.
    • 14 Jul 2009 Trial phase changed from II to III as reported by ClinicalTrials.gov.
    • 14 Apr 2009 Actual initiation date changed from Mar 2007 to Dec 2006 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top